87 related articles for article (PubMed ID: 3090301)
1. [Clinical study of THP-adriamycin in patients with advanced gastric cancer].
Hayakawa M; Morise K; Ohno R; Saito H
Gan No Rinsho; 1986 Jun; 32(7):762-8. PubMed ID: 3090301
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer].
Koda K; Kure T; Terada S; Arai R; Morita K; Hirayama M; Terui T; Fukushi A; Yoshizaki N; Nakazawa O
Gan No Rinsho; 1987 Sep; 33(11):1329-35. PubMed ID: 3118075
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
[TBL] [Abstract][Full Text] [Related]
4. [A randomized controlled trial with methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) vs 5-FU alone in advanced or recurrent gastric carcinoma. Tokai Hokuriku THP Study Group].
Yamamura Y; Miyazaki I; Ogawa M; Yonemura Y; Tanemura H; Kito T; Hamajima N; Saji S; Kosaka T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1543-8. PubMed ID: 9725047
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
[TBL] [Abstract][Full Text] [Related]
6. [New combination therapy with FTM [5-FU, pirarubicin (THP) and MMC] for treatment of inoperable advanced gastric cancer].
Sakai Y; Miyasaka Y; Yo S; Nagayama K; Fukasaku T; Kusano F; Sakuma I; Maekawa N; Sazaki N; Tazawa J
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2233-8. PubMed ID: 9422067
[TBL] [Abstract][Full Text] [Related]
7. [FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
Hayakawa M; Morise K; Oka Y; Suga S; Suzuki T; Kaneshiro K; Tsunekawa H; Hayashi N; Umemura K; Yoshida H
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3073-9. PubMed ID: 2847659
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
9. [A phase I study of combination chemotherapy using TS-1 and pirarubicin (THP) for advanced gastric cancer].
Yamamura Y; Kodera Y; Tanemura H; Oshita H; Miyashita K; Fujimura T;
Gan To Kagaku Ryoho; 2004 Mar; 31(3):361-5. PubMed ID: 15045941
[TBL] [Abstract][Full Text] [Related]
10. [Co-administration of adriamycin and 5-fluorouracil for the treatment of advanced stomach cancer].
Inoue K; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Miyamoto H; Ikeda K; Usui N; Nakada H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1197-201. PubMed ID: 6870296
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)].
Sakai Y; Kusano F; Yamamoto C; Maekawa N; Sasaki N; Tajiri K; Tazawa J
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1271-4. PubMed ID: 8031171
[TBL] [Abstract][Full Text] [Related]
12. [A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer].
Yamamura Y; Kodera Y; Kito T
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1407-10. PubMed ID: 7668879
[No Abstract] [Full Text] [Related]
13. [PMC (pharmacokinetic modulating chemotherapy) for advanced gastric cancer].
Fujiwara Y; Kusunoki M; Nakagawa K; Nakao K; Itoh R; Yamamura T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2175-81. PubMed ID: 10635301
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
[TBL] [Abstract][Full Text] [Related]
16. [A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer].
Abe O; Tominaga T; Enomoto K; Abe R; Iino Y; Koyama H; Fujimoto M; Nomura Y; Tanaka T
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2160-8. PubMed ID: 3717960
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
[TBL] [Abstract][Full Text] [Related]
18. [Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin].
Toda K; Asaishi K; Okazaki M; Okazaki Y; Okazaki A; Sato H; Mikami T; Watanabe Y; Hayasaka H; Narimatsu E
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3011-4. PubMed ID: 2782905
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of recurrent gastric cancer for which combination chemotherapy with pirarubicin, cis-platinum and 5-fluorouracil were markedly effective].
Katsumata K; Yamamoto K; Ashizawa T; Sumi T; Yamashita S; Nagashima K; Murohashi T; Majima T; Mori M; Takahashi S; Koyanagi Y
Gan To Kagaku Ryoho; 2000 Jan; 27(1):113-6. PubMed ID: 10660742
[TBL] [Abstract][Full Text] [Related]
20. [A case of nonresectable esophageal cancer treated by the combination of cisplatin, 5-fluorouracil and THP-adriamycin].
Anai H; Toda T; Ichiyoshi Y; Miura O; Matsuzaki K; Minamisono Y; Nagasaki S
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1241-4. PubMed ID: 8333752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
